High levels of interleukin-6 are associated with final infarct size and adverse clinical events in patients with STEMI.
Ingvild Maria TøllefsenChristian SheteligIngebjørg SeljeflotJan EritslandPavel HoffmannGeir Øystein AndersenPublished in: Open heart (2022)
NCT00922675.